Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06417736
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2024-05-12
Brief Title:
Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Sponsor:
Womens Hospital School Of Medicine Zhejiang University
Organization:
Womens Hospital School Of Medicine Zhejiang University
Study Overview
Official Title:
Prospective Clinical Study of Fertility-sparing Treatment With a Membrane-inhibiting Formula Combined With Oral Progestins for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women
Status:
RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the effect and adverse side effects of membrane-inhibiting formula plus oral progestins as fertility-preserving treatment in patients with early-stage endometrial cancer and endometrial hyperplasia research questionsWhen taken with oral progestins does the drug membrane-inhibiting formula shorten the time required for complete endometrial remission What medical problems do participants have when taking drug membrane-inhibiting formula plus oral progestins Efficacy side effects recurrence pregnancy and time to obtain pregnancy in different molecular classifications of POLE-mutated mismatch repair-deficientMMRd p53 wild typep53wt and p53-abnormalp53abn
Participants will Take drug membrane-inhibiting formula plus oral progestins every day Visit the clinic once every 3 months for checkups tests and hysteroscopy Keep a diary of examination results and pathology
Participants will Take drug membrane-inhibiting formula plus oral progestins every day Visit the clinic once every 3 months for checkups tests and hysteroscopy Keep a diary of examination results and pathology
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None